The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

  • Research Groups
    • Kedzierska Group

      Katherine’s team researches the immunity to viral infections, especially the newly emerged influenza viruses. Her work spans basic research – from mouse experiments to human immunity, through to clinical settings, with a particular focus on understanding universal CD8+ T cell immunity to influenza viruses. Her studies aim to identify key correlates of severe and fatal influenza disease in high-risk groups including children, the elderly and Indigenous Australians. 

      Other work areas include:Influenza


    Current Projects

    • To define ‘universal’ influenza-specific CD8+ T-cell responses across different HLAs

      Although CD8+ T-cells confer universal immunity to distinct influenza viruses and may limit influenza-induced mortality, the overall efficacy of human influenza A virus-specific CD8+ T cells directed at any conserved and/or variable epitopes remains unclear. Here, Katherine’s group aims to (i) understand influenza-specific CD8+ T-cell immunity across different HLAs; (ii) determine the efficacy of immunodominant CD8+ T-cell responses in humans; (iii) evaluate the conservation of immunogenic epitopes in birds, pigs and humans through analysis of viral evolutionary history (with Associate Professor Vijaykrishna from Duke-NUS in Singapore); (iv) understand immunity to clinically important but understudied influenza B viruses. 

    • To identify correlates of severe and fatal influenza disease in high-risk groups

      Enhanced susceptibility to influenza and exacerbated disease severity can reflect over-activation of the innate immune system, impaired humoral and cellular immunity and be influenced by host genetic factors (HLA or IFITM3). Understanding the key deficits that lead to severe disease in high-risk groups will provide insight into how immune interventions might minimise the incidence of severe influenza pneumonia. Katherine’s group studies the contributions of virological, immunological, clinical and host factors to susceptibility, clinical severity and outcome for different high-risk groups: (i) young children and the elderly (with Dr Crowe from Deepdene Surgery); (ii) Indigenous Australians (with Associate Professor Tong from Menzies in Darwin and Professor Miller from Griffith University in New South Wales), (iii) high-risk groups hospitalised through FluCAN (with Associate Professors Cheng and Kotsimbos) and Shanghai Public Clinical Hospital at Fudan University in China (with Professor Xu).

    • To unravel mechanisms underlying the early generation of human CTL memory

      Though immunological memory is of pivotal importance for vaccine development and immunotherapy, the molecular and differentiation pathways central to the generation of (particularly) human CD8+ T-cell memory are poorly understood. Here, Katherine’s group aims to (i) establish the key factors driving the early establishment of influenza-specific T cell memory; (ii) To define molecular processes involved in CD27-mediated co-stimulation of human T cells. As memory is crucial for protection against recurrent infections, this work will provide novel insights into the generation and efficacy of human T cell memory populations and inform effective CD27-mediated stimulation for immunotherapy. 


    Lab Team

    Kedzierska  Group

    • Dr Liyen Loh
      Postdoctoral fellow
    • Dr Zhongfang Wang
      Postdoctoral fellow
    • Dr E Bridie Clemens
      NHMRC Peter Doherty Fellow
    • Dr Oanh Nguyen
      Postdoctoral fellow
    • Emma Grant
      PhD student
    • Nicola Bird
      Research Assistant
    • Sergio Quinones Parra
      PhD student
    • Sneha Sant
      PhD student
    • Marios Koutsakos
      PhD student
    • Hayley Hayley
      Research Assistant
    • Simone Neussing
    • Jesseka Chadderton